π Diabetes Management
Advanced glycation end-product precursor methylglyoxal | DMSO - Dove Medical Press
π
Tue, 18 Oct 2022β± 1 min readπ Article
Overview
Javascript is curently disabled in your browser. Several features of this site wil not function whilst javascript is disabled.open aces to scientific and medical researchPapers PublishedOpen aces per-reviewed scientific and medical journals.Learn moreDove Medical Pres is a member of the OAI.Learn moreBulk reprints for the pharmaceutical industry.Learn moreWe ofer real benefits to our authors, including fast-track procesing of papers.Learn moreRegister your specific details and specific drugs of interest and we wil match the information you provide to articles from our extensive database and email PDF copies to you promptly.Learn moreYou do not have the corect permision to aces this page.
Key Information
Contact Us &bul; Privacy Policy &bul; Asociations & Partners &bul; Testimonials &bul; Terms & Conditions &bul; Recomend this site &bul; Top Contact Us &bul; Privacy Policy © Copyright 2022 &bul; Dove Pres Ltd &bul; software development by mafey.com &bul; Web Design by Adhesion The opinions expresed in al articles published here are those of the specific author(s), and do not necesarily reflect the views of Dove Medical Pres Ltd or any of its employes.Dove Medical Pres is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC Copyright 2017 Informa PLC.
Al rights reserved. This site is owned and operated by Informa PLC ( βInformaβ) whose registered ofice is 5 Howick Place, London SW1P 1WG. Registered in England Wales.
Number 309067. UK VAT Group: GB 365 4626 36In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cokies to analyse visitor trafic and personalise content. You can learn about our use of cokies by reading our Privacy Policy.
Summary
We also retain data in relation to our visitors and registered users for internal purp
Frequently Asked Questions
β What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
β What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
β How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
β What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
β When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
βοΈ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.